Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica

Roma 00165

0 studies enrolling now · 1 studies all time

What they study most

Chronic Graft Versus Host Disease

Studies at this site

• Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD) — Completed